Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2012
10/09/2012CA2550598C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method and their use in therapy
10/09/2012CA2480389C Modified saccharides having improved stability in water
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/04/2012WO2012135561A1 Formulations comprising 2 -amino- 2- [2- (4 - octylphenyl) ethyl] propane -1, 3 - diol
10/04/2012WO2012135132A1 Compositions and methods to immunize against hepatitis c virus
10/04/2012WO2012134591A2 Plasmodium falciparum antigens
10/04/2012WO2012133948A1 Composition for allotransplantation cell therapy, said composition containing ssea-3 positive pluripotent stem cell capable of being isolated from body tissue
10/04/2012WO2012133914A1 Potentiator of cancer immunity containing rankl antagonist
10/04/2012WO2012133399A1 Immunosuppressive cell-capturing material and immunosuppressive cell-capturing column
10/04/2012WO2012133198A1 Nutritional composition for inflammatory diseases
10/04/2012WO2012132335A1 Method for manufacturing culture medium, and culture medium manufactured by method
10/04/2012WO2012131618A1 A composition comprising pooled wharton's jelly derived mesenchymal stem cells and methods thereof
10/04/2012WO2012131468A1 Crystalline forms of fused amino pyridines as hsp90 inhibitors
10/04/2012WO2012131413A1 Crystalline forms of fused amino pyridines as hsp90 inhibitors
10/04/2012WO2012131069A1 Short chain fatty acids and their derivatives for use in treatment immunogenic disorders
10/04/2012WO2012131053A1 Methods of treating immune disorders with single domain antibodies against tnf-alpha
10/04/2012WO2012130915A1 Spiroalkene carboxamide derivatives and their use as chemokine receptor modulators
10/04/2012WO2012129967A1 New aminopyridine compounds, the preparation method, the pharmaceutical compositions comprising these compounds and the uses thereof
10/04/2012WO2012129914A1 3-amino-2-hydroxy-4-phenyl-valyl-isoleucine and preparation method and use thereof
10/04/2012WO2012129767A1 Pharmaceutical composition comprising cation modified agarose hydrogel and nucleic acid, preparation method and use thereof
10/04/2012WO2012129645A1 Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
10/04/2012WO2012083445A8 Virus like particle production in plants
10/04/2012WO2006089690A9 Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
10/04/2012US20120255047 Porcine Animals Lacking Any Expression of Functional Alpha 1,3 Galactosyltransferase
10/04/2012US20120255045 Inducible small rna expression constructs for targeted gene silencing
10/04/2012US20120253041 New phenylalanine derivatives
10/04/2012US20120253039 Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds
10/04/2012US20120252896 Methods and compositions for modulation of t-cells via the kynurenine pathway
10/04/2012US20120252864 Substituted isoindoline-1,3-dione derivatives
10/04/2012US20120252822 Inhibitors of bruton's tyrosine kinase
10/04/2012US20120252821 Inhibitors of bruton's tyrosine kinase
10/04/2012US20120252817 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
10/04/2012US20120252815 Inhibitors of sphingosine kinase
10/04/2012US20120252809 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
10/04/2012US20120252799 Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/04/2012US20120252798 Indole compounds as an inhibitor of cellular necrosis
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252789 Inhibitors of sphingosine kinase
10/04/2012US20120252783 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
10/04/2012US20120252782 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
10/04/2012US20120252781 Benzodiazepine Bromodomain Inhibitor
10/04/2012US20120252779 Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
10/04/2012US20120252778 Pyrazolo pyrimidine derivatives
10/04/2012US20120252777 Thiazolopyrimidine compounds
10/04/2012US20120252742 Human Single-Chain T Cell Receptors
10/04/2012US20120252740 Hdac inhibitors and therapeutic methods of using same
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120252731 Co-Administration of An Agent Linked to an Internalization Peptide With an Anti-Inflammatory
10/04/2012US20120252726 Novel neurotrophic factors
10/04/2012US20120252723 Regulating the Amino Acid Pool Used for the Acute-Phase Protein Synthesis
10/04/2012US20120252722 Metal-binding therapeutic peptides
10/04/2012US20120251616 Tocopherols, Tocotrienols, Other Chroman and Side Chain Derivatives and Uses Thereof
10/04/2012US20120251581 Novel Compound and Methods for its Production
10/04/2012US20120251577 Selectively disrupted whole-cell vaccine
10/04/2012US20120251572 Hepatitis c virus vaccine composition
10/04/2012US20120251571 Rnase l-mediated cleavage products and uses thereof
10/04/2012US20120251570 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines
10/04/2012US20120251569 Composition for treating hbv infection
10/04/2012US20120251568 Recombinant influenza viruses and uses thereof
10/04/2012US20120251566 Saponin adjuvant compositions and methods relating thereto
10/04/2012US20120251565 Compositions and methods for preventing or treating burkholderia infection
10/04/2012US20120251564 Reovirus compositions and methods of use
10/04/2012US20120251563 Modulation of immune response by non-peptide binding stress response polypeptides
10/04/2012US20120251562 Inhibitors of the PP1/GADD34 Complex for the Treatment of a Condition Requiring an Immunosuppressive Activity
10/04/2012US20120251560 Conjugated lipomers and uses thereof
10/04/2012US20120251552 Methods of generating improved antigen-binding agents using chain shuffling and optionally somatic hypermutation
10/04/2012US20120251550 Crystalline anti-hTNFalpha antibodies
10/04/2012US20120251549 Complement inhibitors and uses thereof
10/04/2012US20120251547 Il-17 receptor a antigen binding proteins
10/04/2012US20120251542 Anti-toxin vaccine compositions and methods of use thereof
10/04/2012US20120251540 Stabilized single domain antibodies
10/04/2012US20120251537 Compositions and methods for the treatment of infections and tumors
10/04/2012US20120251525 Method of utilizing azelaic acid esters to modulate communications mediated by biological molecules
10/04/2012US20120251523 Methods of Modulating TGFbeta Signaling
10/04/2012US20120251514 Modulated programmed death ligand-1
10/04/2012US20120251495 Pterin based therapies for inflammatory conditions
10/04/2012US20120251494 Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
10/04/2012US20120251491 Fused tricyclic aryl compounds useful for the treatment of viral diseases
10/04/2012US20120251454 Human Anti-IL-23 Antibodies, Compositions, Methods and Uses
10/04/2012US20120251444 Treatment of liver disorders by administration of rap conjugates
10/04/2012US20120251441 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with diseases like cachexia and correction of adverse effects of drugs such as immunosuppression, neutropenia and lymphopenia, comprising the association or combination of a biological response modifier specially selected and other substances with antineoplastic action and/or other treatments
10/04/2012CA2831600A1 Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
10/04/2012CA2831294A1 Compositions and methods to immunize against hepatitis c virus
10/04/2012CA2831247A1 Cancer immunopotentiating agent containing rankl antagonist
10/04/2012CA2831111A1 Cd37-binding molecules and immunoconjugates thereof
10/04/2012CA2830305A1 Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
10/03/2012EP2505586A1 Indole compound and pharmaceutical use thereof
10/03/2012EP2504328A1 Novel compounds as receptor modulators with therapeutic utility
10/03/2012EP2504323A1 Novel compounds as receptor modulators with therapeutic utility
10/03/2012EP2504028A2 Simultaneous inhibition of pd-l1/pd-l2
10/03/2012EP2504007A1 Novel therapeutic methods for treating inflammation and immune system disorders
10/03/2012EP2504004A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina
10/03/2012CN1993463B Follistatin mutant polypeptide
10/03/2012CN1972714B Methods of treating autoimmune and inflammatory diseases
10/03/2012CN102712923A Anti-iga1 antibody
10/03/2012CN102712658A N-containing heteroaryl derivatives as jak3 kinase inhibitors
10/03/2012CN102712641A MK2 inhibitors
10/03/2012CN102712640A Tricyclic heterocyclic compounds, compositions and methods of use thereof
10/03/2012CN102712636A Compounds and compositions as TLR activity modulators
10/03/2012CN102712626A Piperazine compound having a PGDS inhibitory effect
1 ... 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 ... 1172